PKC-mediated HuD–GAP43 pathway activation in a mouse model of antiretroviral painful neuropathy
- 1 March 2014
- journal article
- Published by Elsevier in Pharmacological Research
- Vol. 81, 44-53
Abstract
No abstract availableKeywords
Funding Information
- MIUR
This publication has 51 references indexed in Scilit:
- A clinically relevant rodent model of the HIV antiretroviral drug stavudine induced painful peripheral neuropathyPain, 2013
- Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury painBrain Research, 2011
- Pharmacological Treatment of Painful HIV-Associated Sensory Neuropathy: A Systematic Review and Meta-Analysis of Randomised Controlled TrialsPLOS ONE, 2010
- Guidelines for reporting experiments involving animals: the ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- Oral uridine supplementation antagonizes the peripheral neuropathy and encephalopathy induced by antiretroviral nucleoside analoguesAIDS, 2010
- Supraspinal role of protein kinase C in oxaliplatin-induced neuropathy in ratPain, 2009
- Characterization of rodent models of HIV-gp120 and anti-retroviral-associated neuropathic painBrain, 2007
- CXCR4 chemokine receptor signaling mediates pain hypersensitivity in association with antiretroviral toxic neuropathyBrain, Behavior, and Immunity, 2007
- Protein kinase C in pain: Involvement of multiple isoformsPharmacological Research, 2007
- The RNA-Binding Protein HuD Binds Acetylcholinesterase mRNA in Neurons and Regulates its Expression after AxotomyJournal of Neuroscience, 2007